Moderna, Inc. (NASDAQ:MRNA) Receives $53.58 Average Price Target from Analysts
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) has been assigned a consensus recommendation of “Hold” from the twenty-three brokerages that are presently covering the stock, MarketBeat reports. Four analysts have rated the stock with a sell recommendation, fifteen have issued a hold recommendation, three have assigned a buy recommendation and one has issued a strong […]
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) has been assigned a consensus recommendation of “Hold” from the twenty-three brokerages that are presently covering the stock, MarketBeat reports. Four analysts have rated the stock with a sell recommendation, fifteen have issued a hold recommendation, three have assigned a buy recommendation and one has issued a strong […]
